Terapro <6627> has rebounded significantly. They announced the monthly trend for May the previous day, which seems to have led to a reassessment. Monthly sales in May increased by 16.3% compared to the same month last year, and has reached double-digit growth for two consecutive months. Since disclosing monthly sales trends in 2022, the company has continued to post positive growth, but in April 2024, it recorded double-digit growth for the first time in 14 months. May appears to be a more significant increase in revenue, and is considered a return to a significant expansion stage.
テラプロ---大幅反発、5月売上高は2カ月連続での2ケタ成長に
Terapro - significant rebound, May revenue has achieved double-digit growth for two consecutive months.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.